---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-023424"
form_type: "8-K"
ticker: "SODI"
cik: "0000091668"
company_name: "SOLITRON DEVICES INC"
filed_at: "2026-07-13T19:34:56+00:00"
generated_at: "2026-07-13T19:36:19.369279+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solitron Devices Q1 FY2027 net sales $5.44M (+101% YoY), net income $0.99M vs loss; retains banker for strategic review

## Summary
- Net sales $5.44M, up 101% YoY; net income $0.99M ($0.46 EPS) vs net loss of $0.34M ($0.16 loss) in prior year.
- Net bookings fell 48% to $1.45M; backlog up 28% to $23.34M, further boosted by $5.04M post-quarter order to $26.97M.
- Retained investment banker to explore strategic alternatives including merger, sale, or special dividend; no assurance of outcome.
- Contingent consideration expense of $0.33M related to MEI earn-out; no actual income taxes due due to deferred tax assets.
- U.S. Air Force UPL requests doubling AMRAAM production to 2,400/yr by 2028; Solitron is key supplier, needs Congressional approval.

## SEC filing metadata
- accession: 0001437749-26-023424
- form_type: 8-K
- ticker: SODI
- cik: 0000091668
- company_name: SOLITRON DEVICES INC
- filed_at: 2026-07-13T19:34:56+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/91668/000143774926023424/0001437749-26-023424-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/91668/000143774926023424/sodi20260708_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-023424
- JSON: https://secwatch.observer/filing/0001437749-26-023424.json
- Plain text: https://secwatch.observer/filing/0001437749-26-023424.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.